Geode Capital Management, LLC Aurinia Pharmaceuticals Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,766,370 shares of AUPH stock, worth $14.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,766,370

Previous 1,763,602 0.16%

Holding current value

$14.3 Million

Previous $10.1 Million 28.57%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$5.32 - $7.33 $14,725 - $20,289	2,768 Added 0.16%	1,766,370 $12.9 Million
Q2 2024 Aug 09, 2024	BUY	$4.81 - $5.78 $772,110 - $927,817	160,522 Added 10.01%	1,763,602 $10.1 Million
Q1 2024 May 13, 2024	BUY	$4.93 - $9.31 $167,343 - $316,018	33,944 Added 2.16%	1,603,080 $8.03 Million
Q4 2023 Feb 13, 2024	BUY	$7.13 - $9.49 $579,968 - $771,935	81,342 Added 5.47%	1,569,136 $14.1 Million
Q3 2023 Nov 13, 2023	BUY	$7.77 - $12.27 $598,507 - $945,133	77,028 Added 5.46%	1,487,794 $11.6 Million
Q2 2023 Aug 11, 2023	BUY	$8.96 - $11.69 $733,931 - $957,551	81,912 Added 6.16%	1,410,766 $13.7 Million
Q1 2023 May 15, 2023	BUY	$5.94 - $11.27 $474,606 - $900,473	79,900 Added 6.4%	1,328,854 $14.6 Million
Q4 2022 Feb 13, 2023	BUY	$4.11 - $8.14 $180,724 - $357,932	43,972 Added 3.65%	1,248,954 $5.4 Million
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $275,850 - $513,181	41,419 Added 3.56%	1,204,982 $9.06 Million
Q2 2022 Aug 12, 2022	BUY	$8.95 - $12.8 $9.41 Million - $13.5 Million	1,051,466 Added 938.0%	1,163,563 $11.7 Million
Q1 2022 May 13, 2022	BUY	$10.05 - $22.48 $75,495 - $168,869	7,512 Added 7.18%	112,097 $1.39 Million
Q4 2021 Feb 11, 2022	SELL	$17.78 - $33.08 $329,374 - $612,807	-18,525 Reduced 15.05%	104,585 $2.39 Million
Q3 2021 Nov 12, 2021	SELL	$10.93 - $23.55 $174,388 - $375,740	-15,955 Reduced 11.47%	123,110 $2.72 Million
Q2 2021 Aug 13, 2021	BUY	$10.0 - $14.52 $111,900 - $162,478	11,190 Added 8.75%	139,065 $1.8 Million
Q1 2021 May 12, 2021	BUY	$12.3 - $18.73 $16,924 - $25,772	1,376 Added 1.09%	127,875 $1.66 Million
Q4 2020 Feb 12, 2021	BUY	$12.94 - $16.05 $136,853 - $169,744	10,576 Added 9.12%	126,499 $1.77 Million
Q3 2020 Nov 13, 2020	BUY	$13.19 - $16.66 $237,644 - $300,163	18,017 Added 18.4%	115,923 $1.71 Million
Q2 2020 Aug 13, 2020	BUY	$14.12 - $18.33 $27,435 - $35,615	1,943 Added 2.02%	97,906 $1.59 Million
Q1 2020 May 14, 2020	BUY	$11.34 - $21.46 $220,007 - $416,345	19,401 Added 25.34%	95,963 $1.39 Million
Q4 2019 Feb 13, 2020	BUY	$3.88 - $21.42 $44,918 - $247,979	11,577 Added 17.81%	76,562 $1.55 Million
Q2 2018 Aug 14, 2018	BUY	$5.06 - $6.36 $202,622 - $254,679	40,044 Added 160.55%	64,985 $365,000
Q2 2017 Aug 14, 2017	BUY	N/A	24,941	24,941 $152,000

Others Institutions Holding AUPH

# of Institutions

209

Shares Held

58.7M

Call Options Held

1.14M

Put Options Held

1.51M

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.15B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Aurinia Pharmaceuticals Inc. Transaction History